Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy

Blood

Volumn 93, Issue 6, 1999, Pages 1869-1874

  Imashuku, Shinsaku ^a   Hibi, Shigeyoshi ^b   Ohara, Toshio ^b   Iwai, Asayuki ^b   Sako, Masahiro ^b   Kato, Masahiko ^b   Arakawa, Hirokazu ^b   Sotomatsu, Manabu ^b   Kataoka, Satoshi ^b   Asami, Keiko ^b   Hasegawa, Daijiro ^b   Kosaka, Yoshiyuki ^b   Sano, Kimihiko ^b   Igarashi, Noboru ^b   Maruhashi, Keiko ^b   Ichimi, Ryouji ^b   Kawasaki, Hajime ^b   Maeda, Naoko ^b   Tanizawa, Akihiko ^b   Arai, Koji ^b   Abe, Takanori ^b   Hisakawa, Hiroaki ^b   Miyashita, Hidemasa ^b   Henter, Jan Inge ^b   more..

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; EPIPODOPHYLLOTOXIN; ETOPOSIDE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; VINCRISTINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW SUPPRESSION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTIOCYTOSIS; HUMAN; INFANT; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONONUCLEAR PHAGOCYTE; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT PLANNING;

CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DEXAMETHASONE; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; ETOPOSIDE; FEMALE; GLUCOCORTICOIDS; HERPESVIRUS 4, HUMAN; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; PREDNISOLONE; REMISSION INDUCTION; STEROIDS;

EID: 0033559748     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Henter J-I, Elinder G, Ost A, and the HLH Study Group of the Histiocyte Society: Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 18:29, 1991
2. Henter J-I, Arico M, Egeler RM, Elinder G, Favara BE, Filipovich AH, Gadner H, Imashuku S, Janka Schaub G, Komp D, Ladisch S, Webb D, for the HLH Study Group of the Histiocyte Society: HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 28:342, 1997
3. Favara BE: Hemophagocytic lymphohistiocytosis: A hemophagocytic syndrome. Semin Diagn Pathol 9:62, 1992
4. Janka G, Imashuku S, Elinder G, Schneider M, Henter J-I: Infection- and malignancy-associated hemophagocytic syndromes. Secondary Hemophagocytic Lymphohistiocytosis. Hematol Oncol Clin North Am 12:435, 1998
5. Christensson B, Braconier JH, Winqvist I, Relander T, Dictor M: Fulminant course of infectious mononucleosis with virus-associated hemophagocytic syndrome. Scand J Infect Dis 19:373, 1987
6. Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT: Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 111:530, 1987
7. Wilson ER, Malluh A, Stagno S, Crist WM: Fatal Epstein-Barr virus-associated hemophagocytic syndrome. J Pediatr 98:260, 1981
8. Kikuta H, Sakiyama Y, Matsumoto S, Oh-Ishi T, Nakano T, Nagashima T, Oka T, Hironaka T, Hirai K: Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood 82:3259, 1993
9. Mori M, Kurozumi H, Akagi K, Tanaka Y, Imai S, Osato T: Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis. N Engl J Med 327:58, 1992
10. Gaillard F, Mechinaud-Lacroix F, Papin S, Moreau A, Mollat C, Fiche M, Peltier S, DeFaucal PJ, Rousselet MC, Praloran V, Harousseau J-L: Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am J Clin Pathol 98:324, 1992
11. Dolezal MV, Kamel OW, van de Rijn M, Cleary ML, Sibley RK, Warnke RA: Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. Am J Clin Pathol 103:189, 1995
12. Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai M, Kobayashi N, Mizutani S: Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 92:1444, 1993
13. Su IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM: Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 72: 2019, 1993
14. Ishii E, Ohga S, Aoki T, Yamada S, Sako M, Tasaka H, Kuwano A, Sasaki M, Tsunematsu Y, Ueda K: Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: Correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol 85:93, 1991
15. Imashuku S, Hibi S, Fujiwara F, Ikushima S, Todo S: Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Br J Haematol 88:656, 1994
16. Fujiwara F, Hibi S, Imashuku S: Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 15:92, 1993
17. Chen R-L, Lin K-H, Lin D-T, Su IJ, Huang LM, Lee PI, Hseih KH, Lin KS, Lee CY: Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol 89:282, 1995
18. Sullivan JL, Woda BA, Herrod HG, Koh G, Rivara FP, Mulder C: Epstein-Barr virus-associated hemophagocytic syndrome: Virological and immunopathological studies. Blood 65:1097, 1985
19. Yoshimura N, Nishioka S, Tanida T, Shima M, Ikemoto E, Kamei K, Agawa Y, Nishino N: An adult case of virus-associated hemophagocytic syndrome (VAHS) and a review of this syndrome in adults in Japan. Kansenshogaku Zasshi 65:472, 1991
20. Inoue T, Furukawa Y, Yamane T, Hiyoshi M, Sasaki A, Kishida T, Im T, Tatsumi N, Sannomiya Y: Virus-associated hemophagocytic syndrome due to EB virus. Rinsho Ketsueki 30:1826, 1989
21. Nomura S, Koshikawa K, Hamamoto K, Okubo S, Yasunaga K: Steroid and gamma globulin therapy against virus-associated hemophagocytic syndrome. Rinsho Ketsueki 33:1242, 1992
22. Imashuku S: Case records of pediatric hemophagocytic syndrome. Nihon Ijishinpo 3678:43, 1994
23. Imashuku S, Hibi S, Todo S: Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 130:352, 1997
24. Teshima T, Miyaji R, Fukuda M, Ohshima K: Bone-marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia. Lancet 347:1124, 1996
25. Imashuku S, Naya M, Yamori M, Nakabayashi Y, Hojo M, Kihara A, Tabata Y, Akioka C, Hibi S, Todo S: Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis. Bone Marrow Transplant 19:1059, 1997
26. Sumaya CV, Ench Y: Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 75:1101, 1985
27. Telenti A, Marshall WF, Smith TF: Detection of Epstein-Barr virus by polymerase chain reaction. J Clin Microbiol 28:2187, 1990
28. Sambrook J, Fitsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
29. Toyonaga B, Yanagi Y, Sucu-Foca N, Minden M, Mak TW: Rearrangement of T-cell antigen receptor gene YT35 in human DNA from thymic T-cell lines and functional T-cell clones. Nature 311:385, 1984
30. LeFranc MP, Rabbitts TH: Two tandemly organized human genes encoding the T-cell γ constant region sequences show multiple rearrangement in different T-cell types. Nature 316:464, 1985
31. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883, 1986
32. Imashuku S, Ikushima S, Esumi N, Todo S, Saito M: Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Leuk Lymphoma 3:287, 1991
33. Gill DS, Spencer A, Cobcroft RG: High-dose gamma globulin therapy in the reactive hemophagocytic syndrome. Br J Haematol 88:204, 1994
34. Goulder P, Seward D, Hatton C: Intravenous immunoglobulin in virus-associated hemophagocytic syndrome. Arch Dis Child 65:1275, 1990
35. Freeman B, Rathore MH, Salman E, Joyce MJ, Pitel P: Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. J Pediatr 123:479, 1993
36. Fort DW, Buchanan GR: Treatment of infection-associated hemophagocytic syndrome with immune globulin. J Pediatr 124:332, 1994(1tr)
37. 2). N Engl J Med 308:559, 1983
38. Canellos G, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478, 1992
39. Imashuku S: Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of the most effective treatment. Int J Hematol 66:135, 1997
40. Arico M, Janka G, Fischer A, Henter J-I, Blanche S, Elinder G, Martinetti M, Rusca MP, for the FHL Study Group of the Histiocyte Society: Hemophagocytic lymphohistiocytosis: Diagnosis, treatment, and prognostic factors. Report of 122 children from the international registry. Leukemia 10:197, 1996
41. Esumi N, Hashida T, Matsumura T, Takeuchi Y, Arakawa S, Imashuku S: Malignant histiocytosis in childhood. Clinical features and therapeutic results by combination chemotherapy. Am J Pediatr Hematol Oncol 8:300, 1986
42. Brugieres L, Caillaux JM, Patte C, Rodary C, Bernard A, Kalifa C, Hartmann O, Lemerle J: Malignant histiocytosis; therapeutic results in 27 children treated with a single polychemotherapy regimen. Med Pediatr Oncol 17:193, 1989
43. Henter J-I, Nennesmo I: Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr 130:358, 1997
44. Haddad E, Sulis M-L, Jabado N, Blanche S, Fischer A, Tardieu M: Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 89:794, 1997
45. Stephan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A: Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporine A. Blood 82:2319, 1993
46. Abella EM, Artrip J, Schultz K, Ravindranath Y: Treatment of familial erythrophagocytic lymphohistiocytosis with cyclosporine A. J Pediatr 130:467, 1997
47. Ostrov BE, Athreva BH, Eichenfield AH, Goldsmith DP: Successful treatment of severe cytophagic histiocytic panniculitis with cyclosporine A. Semin Arthritis Rheum 25:404, 1996
48. Gabor EP, Mishalani S, Lee S: Rapid response to cyclosporine therapy and sustained remission in large granular lymphocyte leukemia. Blood 87:1199, 1996
49. Bible KC, Tefferi A: Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis. Br J Haematol 93:406, 1996
50. Grom AA, Passo M: Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr 129:630, 1996
51. Mouy R, Stephan J-L, Pillet P, Haddad E, Hubert P, Prieur AM: Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases. J Pediatr 129:750, 1996
52. Fishman D, Rooney M, Woo P: Successful management of reactive haemophagocytic syndrome in systemic-onset juvenile chronic arthritis. Br J Rheumatol 34:888, 1995
53. + T-CLL associated with eosinophilia and fasciitis. Br J Haematol 80:252, 1992
54. Moreland AA, Robertson DB, Heffner LT: Treatment of cutaneous T cell lymphoma with cyclosporin A. J Am Acad Dermatol 12:886, 1985(1tr)
55. Street ML, Muller SA, Pittelkow MR: Cyclosporine in the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol 23:1084, 1990
56. Ladisch S, Ho W, Matheson D, Pilkington R, Hartman G: Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis. Blood 60:814, 1982
57. Kizaki Z, Fukumochi H, Sawai T, Ishimura K, Esumi N, Nagai T, Todo S, Imashuku S: Exchange transfusion and combination chemotherapy in the treatment of 4 cases of childhood malignant histiocytosis. Rinsho Ketsueki 28:845, 1987
58. Nagasawa M, Okawa H, Yata J: Deleterious effects of high dose γ-globulin therapy on patients with hemophagocytic syndrome. Int J Hematol 60:91, 1994
59. Aukrust P, Froland SS, Liabakk N-B, Muller F, Nordoy I, Haug C, Espevik T: Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 84:2136, 1994
60. Esumi N, Ikushima S, Hibi S, Todo S, Imashuku S: High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 61:2071, 1988
61. Imashuku S, Hibi S, Sako M, Ishida Y, Mugishima H, Chen J, Tsunematsu Y: Soluble interleukin-2 receptor: A useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 86:4706, 1995
62. Smith KJ, Skelton HG III, Giblin WL, James WD: Cutaneous lesions of hemophagocytic syndrome in a patient with T-cell lymphoma and active Epstein-Barr infection. J Am Acad Dermatol 25:919, 1991
63. Kueck BD, Hanson CA, Weissman DE, Bayliss K: Primary lymph node presentation of angiocentric lymphoma associated with features of a hemophagocytic syndrome. Am J Hematol 30:104, 1989
64. Cheng AL, Su IJ, Chen YC, Ven WC, Wang CH: Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer 72:909, 1993